humulin 30/70 (insulin human biosynth inj) suspension
eli lilly canada inc - insulin; insulin isophane (nph) - suspension - 30unit; 70unit - insulin 30unit; insulin isophane (nph) 70unit - insulins
xultophy 100 u/3.6 mg/ml solution for injection (sc)
n/a; importer: novo nordisk pharmaceuticals (philippines), inc.; distributor: novo nordisk pharmaceuticals (philippines), inc. - insulin degludec , liraglutide - solution for injection (sc) - 100 u/3.6 mg/ml
novorapid® flexpen® 100 uml solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - insulin aspart -
levemir® flexpen® 100 uml solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - insulin detemir -
xultophy 100 u/3.6mg per ml solution for injection (sc)
novo nordisk a/s; importer: novo nordisk pharmaceuticals (philippines), inc.; distributor: novo nordisk pharmaceuticals (philippines), inc. - insulin degludec , liraglutide - solution for injection (sc) - 100 u/3.6mg per ml
caninsulin
schering-plough animal health limited - insulin - insulin 0.04 thou iu/ml - endocrine agent (hormone)
caninsulin 40 iu/ml inj. susp. i.m./s.c. vial
intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, crystalline 28 iu/ml; insulin zinc suspension, amorphous 12 iu/ml - insulin (pork) - dog; cat
caninsulin 40 iu/ml inj. susp. s.c./i.m. cartr.
intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, amorphous 12 iu/ml; insulin zinc suspension, crystalline 28 iu/ml - insulin (pork) - dog; cat
ryzodeg 70/30 flextouch
novo nordisk pharmaceuticals ltd - insulin aspart 30 u/ml; insulin degludec 70 u/ml - solution for injection - 100 u/ml - active: insulin aspart 30 u/ml insulin degludec 70 u/ml excipient: glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as acetate - for use in diabetes mellitus in patients aged 6 years and older
arrow - sertraline 100
teva pharma (new zealand) limited - sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline); ; ; - film coated tablet - 100 mg - active: sertraline hydrochloride 111.9mg ((form-i) equivalent to 100mg sertraline) excipient: calcium hydrogen phosphate hyprolose hypromellose macrogol 400 magnesium stearate microcrystalline cellulose polysorbate 80 purified water sodium starch glycolate titanium dioxide - arrow - sertraline is indicated for the treatment of symptoms of depression, including depression accompanied by symptoms of anxiety, in patients with or without a history of mania. following satisfactory response, continuation with sertraline therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes.